P. De-la, Prise en charge selon le stade, p.40

A. Krasteva and V. E. , HEPATITIS B AND C IN DENTISTRY, Journal of IMAB - Annual Proceeding (Scientific Papers), vol.14, issue.2008, pp.1438-1478, 2008.
DOI : 10.5272/jimab.14-2-2008.38

R. Bartenschlager and F. M. , Novel Insights into Hepatitis C Virus Replication and Persistence, Adv Virus Res, vol.63, pp.71-180, 2004.
DOI : 10.1016/S0065-3527(04)63002-8

H. Barth, S. C. , and -. , Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate, Journal of Biological Chemistry, vol.278, issue.42, pp.27841003-27841015, 2003.
DOI : 10.1074/jbc.M302267200

B. Bartosch and D. J. , Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-675, 2003.
DOI : 10.1093/emboj/21.12.2893

URL : https://hal.archives-ouvertes.fr/inserm-00133783

E. Blanchard and B. S. , Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, issue.14, pp.806964-72, 2006.
DOI : 10.1128/JVI.00024-06

URL : https://hal.archives-ouvertes.fr/hal-00105504

G. Brian and Z. K. Pierce, Viral evasion and challenges of hepatitis C virus vaccine development, Curr Opin Virol., pp, vol.20, pp.55-63, 2016.

E. Brochot and D. G. , Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity, Antivir Ther, issue.5, pp.12805-12818, 2007.

C. Brouard, L. S. , and -. , The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014, PLOS ONE, vol.104, issue.Suppl 4, pp.10-0126920, 2015.
DOI : 10.1371/journal.pone.0126920.s006

A. Bruneau, Guide pour la prophylaxie postexposition à des liquides biologiques dans le contexte du travail, 2011.

J. Bukh, The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control, Journal of Hepatology, vol.65, issue.1, pp.65-67, 2016.
DOI : 10.1016/j.jhep.2016.07.035

P. Cacoub, Les manifestations extra-hépatiques au cours de l'infection par le virus de l'hépatite C, 2008.

N. Cannon and D. M. , Evidence for action of ribavirin through the hepatitis C virus RNA polymerase, Journal of Viral Hepatitis, vol.42, issue.35, pp.16595-604, 2009.
DOI : 10.1111/j.1365-2893.2009.01109.x

S. Carrère-kremer and M. C. , Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus, Journal of Virology, vol.76, issue.8, pp.763720-763750, 2002.
DOI : 10.1128/JVI.76.8.3720-3730.2002

C. Charles, &. Roguet-isabelle, and V. Sa, Vidal Recos : recommandations en pratique 2016 185 stratégies thérapeutiques, 2016.

S. Chevaliez, P. L. , and -. , Dépistage de l'infection virale C à partir de sang total capillaire ou de luquide craviculaire: performance des test rapides d'orientation diagnostique (TROD) Lille: Association Française pour l, Etude du Foie, 2013.

Q. Choo and K. G. , Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, vol.244, issue.4902, pp.359-62, 1989.
DOI : 10.1126/science.2523562

C. De-waure and C. C. , Intrafamilial transmission of hepatitis C virus in Italy: a systematic review, Journal of Epidemiology & Community Health, vol.64, issue.10, pp.843-851, 2010.
DOI : 10.1136/jech.2009.087965

J. Delile and R. B. , Hépatite C chez les usagers de drogues. Comment améliorer l'efficacité de la prévention et de la prise en charge ? Alcoologie et Addictologie, pp.385-94, 2008.

S. Deuffic-burban and D. P. , Predicted Effects of Treatment for HCV Infection Vary Among European Countries, Gastroenterology, vol.143, issue.4, pp.143974-85, 2012.
DOI : 10.1053/j.gastro.2012.05.054

. Dhumeaux, Prise en charge des personnes infectées par les virus de l'hépatite B ou de l'hépatite C: rapport de recommandations, 2014.

D. B. Smith and J. B. , Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource, Hepatology, vol.28, issue.244, pp.59318-59345, 2014.
DOI : 10.1002/hep.26744

J. Dumortier, Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation, Liver Transplantation, vol.23, issue.pt 1, pp.221367-78, 2016.
DOI : 10.1002/lt.24505

URL : https://hal.archives-ouvertes.fr/hal-01397762

D. Egger and W. B. , Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex, Journal of Virology, vol.76, issue.12, pp.765974-84, 2002.
DOI : 10.1128/JVI.76.12.5974-5984.2002

A. Farías and R. V. , Detection of hepatitis C virus (HCV) in body fluids from HCV monoinfected and HCV/HIV coinfected patients, Hepatogastroenterology, vol.57, pp.300-304, 2010.

F. Lot and I. , Risque infectieux et conduite à tenir post AES, 2012.

N. Floret, A. Aes-raisin, and W. G. , Sharp Decrease of Reported OccupationalBlood and Body Fluid Exposures in French Hospitals, AES-RAISIN. Infect Control Hosp Epidemiol, issue.8, pp.36963-36971, 2003.

F. Hakkou and S. C. , Manifestations buccales de l'infection virale C chronique, M??decine Buccale Chirurgie Buccale, vol.15, issue.1, pp.31-37, 2009.
DOI : 10.1051/mbcb/2009022

M. Fried and S. M. , Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-82, 2002.
DOI : 10.1056/NEJMoa020047

M. Gale and K. M. Jr, Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance, Clin Diagn Virol, pp.10-12, 1998.

K. Gawlik and G. P. , HCV core protein and virus assembly: what we know without structures, Immunologic Research, vol.12, issue.4, pp.601-611, 2014.
DOI : 10.1007/s12026-014-8494-3

J. Gerberding and R. D. , Intraoperative provider injuries and potential recontacts at San Francisco general hospital, Infect Control Hosp Epidemiol, p.15344, 1994.

R. Germi and C. J. , Cellular glycosamingoslycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption, J Med Virol, issue.2, pp.68206-68221, 2002.
DOI : 10.1002/jmv.10196

R. Haudecoeur, P. M. , and -. , Structure-Activity Relationships in the Development of Allosteric Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibitors: Ten Years of Research, Medicinal Research Reviews, vol.22, issue.5, 2013.
DOI : 10.1002/med.21271

J. Honegger and K. S. , Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses, Nature Medicine, vol.4, issue.11, pp.1529-1562, 2013.
DOI : 10.1038/nm.3351

. Invs, Surveillance et prévention des hépatites B et C en France : bilan et perspectives (numéro thématique), 2009.

M. Jauffret-roustide, P. J. , and -. , Estimation of HIV and hepatitis C prevalence among drug users in France -First results from the ANRS-Coquelicot, Survey. Bulletin Epidémiologique Hebdomadaire, pp.39-40, 2011.

V. Jirasko and M. R. , Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly, Journal of Biological Chemistry, vol.283, issue.42, pp.28328546-62, 2008.
DOI : 10.1074/jbc.M803981200

J. Hoofnagle, Course and outcome of hepatitis C, Hepatology, issue.5, pp.36-57, 2002.

S. K. Kamili, Conclusion., Infection Control & Hospital Epidemiology, vol.52, issue.05, pp.28-519, 2007.
DOI : 10.3109/inf.1978.10.issue-3.01

M. Kane and Z. T. , Identification of Interferon-Stimulated Genes with Antiretroviral Activity, Cell Host & Microbe, vol.20, issue.3, pp.20392-405, 2016.
DOI : 10.1016/j.chom.2016.08.005

J. Kohler and N. J. , Approaches to hepatitis C treatment and cure using NS5A inhibitors, Infect Drug Resist, vol.7, issue.5, pp.41-56, 2014.

F. Laayouni and W. R. , Association hépatite virale C et purpura thrombopénique autoimmun, Journal Africain, vol.7, pp.18-21, 2013.
DOI : 10.1007/s12157-012-0430-3

C. Larsen and C. M. , Gaining Greater Insight into HCV Emergence in HIV-Infected Men Who Have Sex with Men: The HEPAIG Study, PLoS ONE, vol.192, issue.12, p.6, 2011.
DOI : 10.1371/journal.pone.0029322.t004

D. Lavanchy, February) Evolving epidemiology of hepatitis C virus, Clin Microbiol Infect, issue.2, pp.17107-17122, 2011.

L. Strat, Y. , and L. F. , Estimation du nombre de transmissions du VHC de soignants à soignés et évaluation des stratégies de dépisatge des soignants en France, Bull Epidemiol Hebd, pp.2-36, 2006.

M. Lee, Y. H. Group, and R. S. , Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study, Journal of Infectious Diseases, vol.206, issue.4, pp.206469-77, 2012.
DOI : 10.1093/infdis/jis385

URL : http://jid.oxfordjournals.org/cgi/content/short/206/4/469

J. Levy, Adaptation posologique de médicaments prescrits en odontologie chez l'insuffisant rénal et l, 2013.

B. Lindenbach and R. C. , The ins and outs of hepatitis C virus entry and assembly, Nature Reviews Microbiology, vol.92, issue.10, pp.11688-700, 2013.
DOI : 10.1038/nrmicro3098

F. Lot and A. D. , Surveillance des contaminations professionnelles par le VIH, le VHC et le VHB chez le personnel de santé, 2009.

D. Lucidarme and B. A. , Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France, Epidemiol Infect, issue.4, pp.132699-708, 2004.

Y. Ma and Y. J. , NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly, Journal of Virology, vol.82, issue.15, pp.827624-827663, 2008.
DOI : 10.1128/JVI.00724-08

V. Mallet, G. H. , and -. , Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C, Annals of Internal Medicine, vol.149, issue.6, pp.149399-403, 2008.
DOI : 10.7326/0003-4819-149-6-200809160-00006

P. Marcellin and P. F. , Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption, Journal of Hepatology, vol.48, issue.2, pp.48200-48207, 2008.
DOI : 10.1016/j.jhep.2007.09.010

URL : https://hal.archives-ouvertes.fr/inserm-00324950

M. Rerhrhaye and L. A. , Le bilan biologique en odontostomatologie : int??r??t et interpr??tation, Actualit??s Odonto-Stomatologiques, vol.250, issue.250, pp.117-152, 2010.
DOI : 10.1051/aos/2010203

M. Jauffret-roustide, J. P. , and -. , Estimation of HIV and hepatitis C prevalence among drug users in France -First results from the ANRS-Coquelicot, Survey. Bull Epidémiol Hebd, pp.39-40504, 2011.

M. Martinot-peignoux and S. C. , Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin, Hepatology, vol.14, issue.4, pp.511122-511128, 2010.
DOI : 10.1002/hep.23444

S. Maylin and M. , Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C, Gastroenterology, vol.135, issue.3, pp.135821-135830, 2008.
DOI : 10.1053/j.gastro.2008.05.044

L. Meertens and B. C. , Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, issue.23, p.80, 2006.
DOI : 10.1128/JVI.01717-06

C. Meffre and L. S. , Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors, Journal of Medical Virology, vol.15, issue.4, pp.82546-55, 2010.
DOI : 10.1002/jmv.21734

D. Moradpour and P. F. , Replication of hepatitis C virus, Nature Reviews Microbiology, vol.281, issue.6, pp.453-463, 2007.
DOI : 10.1038/nrmicro1645

URL : https://hal.archives-ouvertes.fr/hal-00313684

A. Neumann and L. N. , Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science, issue.5386, pp.282103-282110, 1998.

P. Jimenez, A. , S. E. , and -. , HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt, Gut, vol.59, issue.11, pp.1554-60, 2010.
DOI : 10.1136/gut.2009.194266

E. Paintsil and H. H. , Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users, The Journal of Infectious Diseases, vol.202, issue.7, pp.210-984, 2010.
DOI : 10.1086/656212

J. Pawlostky, NS5A inhibitors in the treatment of hepatitis C, J Hepatol, issue.2, pp.59375-82, 2013.

J. Pawlotsky, New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges, Gastroenterology, vol.146, issue.5, pp.1176-1192, 2014.
DOI : 10.1053/j.gastro.2014.03.003

J. Pawlotsky, Hepatitis C Drugs: Is Next Generation the Last Generation?, Gastroenterology, vol.151, issue.4, pp.151587-90, 2016.
DOI : 10.1053/j.gastro.2016.08.043

F. Péquignot, P. H. , and -. , National assessment of mortality associated and attributable to hepatitis C and hepatitis B viruses in Metropolitan France, Bulletin Epidémiologique Hebdomadaire, vol.27, pp.237-277, 2001.

J. Pillonel and L. D. , Epidémiologie des donneurs de sang infectés par le VHB et le VHC et risque résiduel de transmission de ces infections par transfusion en France, p.71, 2012.

J. Pillonel and L. D. , November) Surveillance épidémiologique des donneurs de sang et risque résiduel de transmission du VIH, de l'HTLV, du VHC et du VHB par transfusion en France entre, Bull Epidemiol Hebd, pp.39-40438, 2008.
DOI : 10.1016/j.tracli.2004.02.004

E. Piver and B. A. , Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture, Gut, pp.2016-311726, 2016.
DOI : 10.1136/gutjnl-2016-311726

S. Pol, Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients, Journal of Hepatology, vol.66, issue.1, pp.168-827830486, 2016.
DOI : 10.1016/j.jhep.2016.08.021

URL : https://hal.archives-ouvertes.fr/hal-01435007

T. Poynard and M. J. , Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, vol.122, issue.5, pp.1221303-1221316, 2002.
DOI : 10.1053/gast.2002.33023

F. Roudot-thoraval and R. I. , Dépistage des hépatites virales et accès aux soins chez les migrants : étude prospective d'une cohorte de 1327 personnes, 2011.

T. Santantonio and W. J. , Acute hepatitis C: Current status and remaining challenges, Journal of Hepatology, vol.49, issue.4, pp.49625-49658, 2008.
DOI : 10.1016/j.jhep.2008.07.005

URL : http://doi.org/10.1016/j.jhep.2008.07.005

L. Seeff, Natural History of chronic hepatitis C. Heparology, pp.35-46, 2002.

C. Semaille, L. S. Group, and P. , Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy, Eurosurveillance, vol.18, issue.28, p.18, 2013.
DOI : 10.2807/1560-7917.ES2013.18.28.20524

D. Sène and D. N. , Actualités des manifestations extrahépatiques associées au virus de l'hépatite C. La revue de médecine interne, pp.388-93, 2007.

C. Shepard and F. L. , Global epidemiology of hepatitis C virus infection, The Lancet Infectious Diseases, vol.5, issue.9, 2005.
DOI : 10.1016/S1473-3099(05)70216-4

D. Smith and B. J. , Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource, Hepatology, vol.28, issue.244, pp.59318-59345, 2014.
DOI : 10.1002/hep.26744

M. Sofia and B. D. , -methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus, Journal of Medicinal Chemistry, vol.53, issue.19, pp.537202-537220, 2010.
DOI : 10.1021/jm100863x

URL : https://hal.archives-ouvertes.fr/hal-01411003

E. Steinmann and P. F. , Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions, PLoS Pathogens, vol.22, issue.7, pp.3-103, 2007.
DOI : 10.1371/journal.ppat.0030103.sg001

T. Tellinghuisen and F. K. , Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein, Journal of Virology, vol.82, issue.3, pp.821073-83, 2008.
DOI : 10.1128/JVI.00328-07

T. Tellinghuisen and M. J. , Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase, Nature, vol.50, issue.7040, pp.435374-435383, 2005.
DOI : 10.1093/NAR/25.24.4876

N. Terrault and D. J. , Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study, Hepatology, vol.32, issue.5 Suppl. 1, pp.57881-57890, 2013.
DOI : 10.1002/hep.26164

H. Thomas, T. M. , and -. , Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C, Journal of Hepatology, vol.31, pp.31152-31161, 1999.
DOI : 10.1016/S0168-8278(99)80393-6

Q. Timour, Prescription des médicaments en cas d'insuffisance hépatique et rénale, 2005.

T. Van-de-laar and P. O. , Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men, Gastroenterology, vol.136, issue.5, pp.1609-1626, 2009.
DOI : 10.1053/j.gastro.2009.02.006

A. Van-der-auwera, Enquête concernant la pratique des anesthésies locales menée auprès des chirurgiens-dentistes exerçant en Alsace, 2006.

R. Verbeeck, Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction, European Journal of Clinical Pharmacology, vol.29, issue.Suppl 1, pp.641147-61, 2008.
DOI : 10.1007/s00228-008-0553-z

C. Wang and C. L. , Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids, Journal of Clinical Virology, vol.50, issue.1, pp.4-7, 2011.
DOI : 10.1016/j.jcv.2010.09.009

D. Webster and K. P. , Hepatitis C, The Lancet, vol.385, issue.9973, pp.3851124-3851159, 2015.
DOI : 10.1016/S0140-6736(14)62401-6

C. Werner and S. J. , Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12, World Journal of Gastroenterology, vol.22, issue.35, pp.228050-228059, 2016.
DOI : 10.3748/wjg.v22.i35.8050